Please Wait.....
Report
Absorbable Fibrin Sealant Patch Market By Application? (General Surgery?, Cardiovascular Surgery?, Wound Management?, Orthopedic Surgery?, Urological Surgery, Ophthalmic Surgery, Others) , By End User (Hospitals and Clinics??, Ambulatory Surgical Centers?, Others) : Global Opportunity Analysis and Industry Forecast, 2024-2033
Market Report I 2024-07-01 I 228 Pages I Allied Market Research
Absorbable Fibrin Sealant Patch Market
The absorbable fibrin sealant patch market was valued at $0.3 billion in 2023 and is projected to reach $0.7 billion by 2033, growing at a CAGR of 7.8% from 2024 to 2033.
An absorbable fibrin sealant patch is a sterile object used in surgical procedures to control bleeding and promote tissue healing. It is a biodegradable patch comprising of equine collagen sponge along with fibrinogen and thrombin, elements which are the key players in the natural blood clotting mechanism of the body. The formulation of the patch involves absorption by the body over time, hence eradicating the need for removal and reducing the risk of infections. The sealant patch is significantly administered during surgeries in which conventional stapling or suturing is difficult or insufficient for hemostasis.
Rise in the conduction of surgical procedures across the globe due to increase in prevalence of cardiovascular, orthopedic, and general health complications is a key driver of the absorbable fibrin sealant patch market. Moreover, surge in the popularity of minimally invasive operations is boosting the adoption of sealant patches as they eliminate the post-recovery intricacies. As an emerging trend, sealant patches that are equally active and effective on both sides are acquiring traction. When compared to the conventional patches, the new sealant patches are reported to be quick by an average of six times, ceasing bleeding in 30 minutes.
However, the cost of surgical procedures involving the use of sealant patches is significantly high as compared to the traditional surgeries, which deters several individuals from preferring them. This acts a major restraint for the absorbable fibrin sealant patch market. On the contrary, constant advancements in sealant patches are expected to present lucrative opportunities for market expansion. According to a study published in Nature, a British scientific journal, next generation of patches are being designed that are projected to provide instant adhesion, possess compatibility with rapid photo-projection, and have the potential to deliver therapeutics.
Segment Review
The absorbable fibrin sealant patch market is segmented into application, end user, and region. On the basis of application, the market is divided into general surgery, cardiovascular surgery, wound management, orthopedic surgery, urological surgery, ophthalmic surgery, and others. As per end user, it is classified into hospitals & clinics, ambulatory surgical centers, and others. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
On the basis of application, the others segment dominates the absorbable fibrin sealant patch market.
As per end user, the hospitals & clinics segment holds a high share of the market.
Region wise, North America is projected to be the highest revenue generator by 2033.
Competition Analysis
The major players operating in the global absorbable fibrin sealant patch market include Johnson & Johnson, Baxter International Inc, Takeda Pharmaceutical Company Limited, Becton, Dickinson and Company, Corza Medical, LifeBond Ltd, Surgical Specialties Corporation, Biegler GmbH, Cohera Medical Inc, and Integra LifeSciences Corporation. These players have adopted various key developmental strategies such as business expansion, new product launches, and partnerships to strengthen their foothold in the market.
Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Application
- General Surgery
- Cardiovascular Surgery
- Wound Management
- Orthopedic Surgery
- Urological Surgery
- Ophthalmic Surgery
- Others
By End User
- Hospitals and Clinics
- Ambulatory Surgical Centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Johnson & Johnson
- Baxter International Inc
- Takeda Pharmaceutical Company Limited
- Becton, Dickinson and Company.
- Corza Medical
- LifeBond Ltd
- Surgical Specialties Corporation
- Biegler GmbH
- Cohera Medical Inc
- Integra LifeSciences Corporation
CHAPTER 1: INTRODUCTION
1.1. Report Description
1.2. Key Market Segments
1.3. Key Benefits
1.4. Research Methodology
1.4.1. Primary Research
1.4.2. Secondary Research
1.4.3. Analyst Tools and Models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET LANDSCAPE
3.1. Market Definition and Scope
3.2. Key Findings
3.2.1. Top Investment Pockets
3.2.2. Top Winning Strategies
3.3. Porter's Five Forces Analysis
3.3.1. Bargaining Power of Suppliers
3.3.2. Threat of New Entrants
3.3.3. Threat of Substitutes
3.3.4. Competitive Rivalry
3.3.5. Bargaining Power among Buyers
3.4. Market Dynamics
3.4.1. Drivers
3.4.2. Restraints
3.4.3. Opportunities
CHAPTER 4: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY TECHNOLOGY
4.1. Market Overview
4.1.1 Market Size and Forecast, By Technology
4.2. Computed Tomography
4.2.1. Key Market Trends, Growth Factors and Opportunities
4.2.2. Market Size and Forecast, By Region
4.2.3. Market Share Analysis, By Country
4.3. Magnetic Resonance Imaging
4.3.1. Key Market Trends, Growth Factors and Opportunities
4.3.2. Market Size and Forecast, By Region
4.3.3. Market Share Analysis, By Country
4.4. Carotid Ultrasound
4.4.1. Key Market Trends, Growth Factors and Opportunities
4.4.2. Market Size and Forecast, By Region
4.4.3. Market Share Analysis, By Country
4.5. Cerebral Angiography
4.5.1. Key Market Trends, Growth Factors and Opportunities
4.5.2. Market Size and Forecast, By Region
4.5.3. Market Share Analysis, By Country
4.6. Electrocardiography
4.6.1. Key Market Trends, Growth Factors and Opportunities
4.6.2. Market Size and Forecast, By Region
4.6.3. Market Share Analysis, By Country
4.7. Echocardiography
4.7.1. Key Market Trends, Growth Factors and Opportunities
4.7.2. Market Size and Forecast, By Region
4.7.3. Market Share Analysis, By Country
4.8. Others
4.8.1. Key Market Trends, Growth Factors and Opportunities
4.8.2. Market Size and Forecast, By Region
4.8.3. Market Share Analysis, By Country
CHAPTER 5: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY END USER
5.1. Market Overview
5.1.1 Market Size and Forecast, By End User
5.2. Hospitals And Clinics
5.2.1. Key Market Trends, Growth Factors and Opportunities
5.2.2. Market Size and Forecast, By Region
5.2.3. Market Share Analysis, By Country
5.3. Ambulatory Surgery Centers
5.3.1. Key Market Trends, Growth Factors and Opportunities
5.3.2. Market Size and Forecast, By Region
5.3.3. Market Share Analysis, By Country
5.4. Diagnostic Laboratories And Imaging Centers
5.4.1. Key Market Trends, Growth Factors and Opportunities
5.4.2. Market Size and Forecast, By Region
5.4.3. Market Share Analysis, By Country
5.5. Others
5.5.1. Key Market Trends, Growth Factors and Opportunities
5.5.2. Market Size and Forecast, By Region
5.5.3. Market Share Analysis, By Country
CHAPTER 6: ACUTE ISCHEMIC STROKE DIAGNOSIS MARKET, BY REGION
6.1. Market Overview
6.1.1 Market Size and Forecast, By Region
6.2. North America
6.2.1. Key Market Trends and Opportunities
6.2.2. Market Size and Forecast, By Technology
6.2.3. Market Size and Forecast, By End User
6.2.4. Market Size and Forecast, By Country
6.2.5. U.S. Acute Ischemic Stroke Diagnosis Market
6.2.5.1. Market Size and Forecast, By Technology
6.2.5.2. Market Size and Forecast, By End User
6.2.6. Canada Acute Ischemic Stroke Diagnosis Market
6.2.6.1. Market Size and Forecast, By Technology
6.2.6.2. Market Size and Forecast, By End User
6.2.7. Mexico Acute Ischemic Stroke Diagnosis Market
6.2.7.1. Market Size and Forecast, By Technology
6.2.7.2. Market Size and Forecast, By End User
6.3. Europe
6.3.1. Key Market Trends and Opportunities
6.3.2. Market Size and Forecast, By Technology
6.3.3. Market Size and Forecast, By End User
6.3.4. Market Size and Forecast, By Country
6.3.5. Germany Acute Ischemic Stroke Diagnosis Market
6.3.5.1. Market Size and Forecast, By Technology
6.3.5.2. Market Size and Forecast, By End User
6.3.6. France Acute Ischemic Stroke Diagnosis Market
6.3.6.1. Market Size and Forecast, By Technology
6.3.6.2. Market Size and Forecast, By End User
6.3.7. UK Acute Ischemic Stroke Diagnosis Market
6.3.7.1. Market Size and Forecast, By Technology
6.3.7.2. Market Size and Forecast, By End User
6.3.8. Italy Acute Ischemic Stroke Diagnosis Market
6.3.8.1. Market Size and Forecast, By Technology
6.3.8.2. Market Size and Forecast, By End User
6.3.9. Spain Acute Ischemic Stroke Diagnosis Market
6.3.9.1. Market Size and Forecast, By Technology
6.3.9.2. Market Size and Forecast, By End User
6.3.10. Rest of Europe Acute Ischemic Stroke Diagnosis Market
6.3.10.1. Market Size and Forecast, By Technology
6.3.10.2. Market Size and Forecast, By End User
6.4. Asia-Pacific
6.4.1. Key Market Trends and Opportunities
6.4.2. Market Size and Forecast, By Technology
6.4.3. Market Size and Forecast, By End User
6.4.4. Market Size and Forecast, By Country
6.4.5. Japan Acute Ischemic Stroke Diagnosis Market
6.4.5.1. Market Size and Forecast, By Technology
6.4.5.2. Market Size and Forecast, By End User
6.4.6. China Acute Ischemic Stroke Diagnosis Market
6.4.6.1. Market Size and Forecast, By Technology
6.4.6.2. Market Size and Forecast, By End User
6.4.7. India Acute Ischemic Stroke Diagnosis Market
6.4.7.1. Market Size and Forecast, By Technology
6.4.7.2. Market Size and Forecast, By End User
6.4.8. Australia Acute Ischemic Stroke Diagnosis Market
6.4.8.1. Market Size and Forecast, By Technology
6.4.8.2. Market Size and Forecast, By End User
6.4.9. South Korea Acute Ischemic Stroke Diagnosis Market
6.4.9.1. Market Size and Forecast, By Technology
6.4.9.2. Market Size and Forecast, By End User
6.4.10. Rest of Asia-Pacific Acute Ischemic Stroke Diagnosis Market
6.4.10.1. Market Size and Forecast, By Technology
6.4.10.2. Market Size and Forecast, By End User
6.5. LAMEA
6.5.1. Key Market Trends and Opportunities
6.5.2. Market Size and Forecast, By Technology
6.5.3. Market Size and Forecast, By End User
6.5.4. Market Size and Forecast, By Country
6.5.5. Brazil Acute Ischemic Stroke Diagnosis Market
6.5.5.1. Market Size and Forecast, By Technology
6.5.5.2. Market Size and Forecast, By End User
6.5.6. Saudi Arabia Acute Ischemic Stroke Diagnosis Market
6.5.6.1. Market Size and Forecast, By Technology
6.5.6.2. Market Size and Forecast, By End User
6.5.7. South Africa Acute Ischemic Stroke Diagnosis Market
6.5.7.1. Market Size and Forecast, By Technology
6.5.7.2. Market Size and Forecast, By End User
6.5.8. Rest of LAMEA Acute Ischemic Stroke Diagnosis Market
6.5.8.1. Market Size and Forecast, By Technology
6.5.8.2. Market Size and Forecast, By End User
CHAPTER 7: COMPETITIVE LANDSCAPE
7.1. Introduction
7.2. Top Winning Strategies
7.3. Product Mapping of Top 10 Player
7.4. Competitive Dashboard
7.5. Competitive Heatmap
7.6. Top Player Positioning, 2023
CHAPTER 8: COMPANY PROFILES
8.1. Koninklijke Philips N.V.
8.1.1. Company Overview
8.1.2. Key Executives
8.1.3. Company Snapshot
8.1.4. Operating Business Segments
8.1.5. Product Portfolio
8.1.6. Business Performance
8.1.7. Key Strategic Moves and Developments
8.2. GE Healthcare
8.2.1. Company Overview
8.2.2. Key Executives
8.2.3. Company Snapshot
8.2.4. Operating Business Segments
8.2.5. Product Portfolio
8.2.6. Business Performance
8.2.7. Key Strategic Moves and Developments
8.3. Canon Inc.
8.3.1. Company Overview
8.3.2. Key Executives
8.3.3. Company Snapshot
8.3.4. Operating Business Segments
8.3.5. Product Portfolio
8.3.6. Business Performance
8.3.7. Key Strategic Moves and Developments
8.4. Simens
8.4.1. Company Overview
8.4.2. Key Executives
8.4.3. Company Snapshot
8.4.4. Operating Business Segments
8.4.5. Product Portfolio
8.4.6. Business Performance
8.4.7. Key Strategic Moves and Developments
8.5. Terumo Corporation
8.5.1. Company Overview
8.5.2. Key Executives
8.5.3. Company Snapshot
8.5.4. Operating Business Segments
8.5.5. Product Portfolio
8.5.6. Business Performance
8.5.7. Key Strategic Moves and Developments
8.6. Stryker
8.6.1. Company Overview
8.6.2. Key Executives
8.6.3. Company Snapshot
8.6.4. Operating Business Segments
8.6.5. Product Portfolio
8.6.6. Business Performance
8.6.7. Key Strategic Moves and Developments
8.7. Fujifilm Holdings Corporation
8.7.1. Company Overview
8.7.2. Key Executives
8.7.3. Company Snapshot
8.7.4. Operating Business Segments
8.7.5. Product Portfolio
8.7.6. Business Performance
8.7.7. Key Strategic Moves and Developments
8.8. Samsung Electronics Co. Ltd
8.8.1. Company Overview
8.8.2. Key Executives
8.8.3. Company Snapshot
8.8.4. Operating Business Segments
8.8.5. Product Portfolio
8.8.6. Business Performance
8.8.7. Key Strategic Moves and Developments
8.9. F. Hoffmann-La Roche Ltd
8.9.1. Company Overview
8.9.2. Key Executives
8.9.3. Company Snapshot
8.9.4. Operating Business Segments
8.9.5. Product Portfolio
8.9.6. Business Performance
8.9.7. Key Strategic Moves and Developments
8.10. Boehringer Ingelheim International GmbH
8.10.1. Company Overview
8.10.2. Key Executives
8.10.3. Company Snapshot
8.10.4. Operating Business Segments
8.10.5. Product Portfolio
8.10.6. Business Performance
8.10.7. Key Strategic Moves and Developments
TABLE 1. GLOBAL ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 2. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR GENERAL SURGERY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 3. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR CARDIOVASCULAR SURGERY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 4. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR WOUND MANAGEMENT, BY REGION, 2024 - 2033 ($BILLION)
TABLE 5. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR ORTHOPEDIC SURGERY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 6. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR UROLOGICAL SURGERY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 7. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OPHTHALMIC SURGERY, BY REGION, 2024 - 2033 ($BILLION)
TABLE 8. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 9. GLOBAL ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 10. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR HOSPITALS AND CLINICS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 11. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 12. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OTHERS, BY REGION, 2024 - 2033 ($BILLION)
TABLE 13. ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY REGION, 2024 - 2033 ($BILLION)
TABLE 14. NORTH AMERICA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 15. NORTH AMERICA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 16. NORTH AMERICA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 17. U.S. ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 18. U.S. ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 19. CANADA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 20. CANADA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 21. MEXICO ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 22. MEXICO ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 23. EUROPE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 24. EUROPE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 25. EUROPE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 26. GERMANY ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 27. GERMANY ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 28. FRANCE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 29. FRANCE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 30. UK ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 31. UK ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 32. ITALY ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 33. ITALY ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 34. SPAIN ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 35. SPAIN ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 36. REST OF EUROPE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 37. REST OF EUROPE ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 38. ASIA-PACIFIC ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 39. ASIA-PACIFIC ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 40. ASIA-PACIFIC ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 41. JAPAN ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 42. JAPAN ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 43. CHINA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 44. CHINA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 45. INDIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 46. INDIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 47. AUSTRALIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 48. AUSTRALIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 49. SOUTH KOREA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 50. SOUTH KOREA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 51. REST OF ASIA-PACIFIC ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 52. REST OF ASIA-PACIFIC ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 53. LAMEA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY COUNTRY, 2024 - 2033 ($BILLION)
TABLE 54. LAMEA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 55. LAMEA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 56. BRAZIL ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 57. BRAZIL ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 58. SAUDI ARABIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 59. SAUDI ARABIA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 60. SOUTH AFRICA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 61. SOUTH AFRICA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 62. REST OF LAMEA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY APPLICATION, 2024 - 2033 ($BILLION)
TABLE 63. REST OF LAMEA ABSORBABLE FIBRIN SEALANT PATCH MARKET, BY END USER, 2024 - 2033 ($BILLION)
TABLE 64. JOHNSON AND JOHNSON: KEY EXECUTIVES
TABLE 65. JOHNSON AND JOHNSON: COMPANY SNAPSHOT
TABLE 66. JOHNSON AND JOHNSON: OPERATING SEGMENTS
TABLE 67. JOHNSON AND JOHNSON: PRODUCT PORTFOLIO
TABLE 68. JOHNSON AND JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 69. BAXTER INTERNATIONAL INC: KEY EXECUTIVES
TABLE 70. BAXTER INTERNATIONAL INC: COMPANY SNAPSHOT
TABLE 71. BAXTER INTERNATIONAL INC: OPERATING SEGMENTS
TABLE 72. BAXTER INTERNATIONAL INC: PRODUCT PORTFOLIO
TABLE 73. BAXTER INTERNATIONAL INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 74. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY EXECUTIVES
TABLE 75. TAKEDA PHARMACEUTICAL COMPANY LIMITED: COMPANY SNAPSHOT
TABLE 76. TAKEDA PHARMACEUTICAL COMPANY LIMITED: OPERATING SEGMENTS
TABLE 77. TAKEDA PHARMACEUTICAL COMPANY LIMITED: PRODUCT PORTFOLIO
TABLE 78. TAKEDA PHARMACEUTICAL COMPANY LIMITED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 79. BECTON, DICKINSON AND COMPANY.: KEY EXECUTIVES
TABLE 80. BECTON, DICKINSON AND COMPANY.: COMPANY SNAPSHOT
TABLE 81. BECTON, DICKINSON AND COMPANY.: OPERATING SEGMENTS
TABLE 82. BECTON, DICKINSON AND COMPANY.: PRODUCT PORTFOLIO
TABLE 83. BECTON, DICKINSON AND COMPANY.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 84. CORZA MEDICAL: KEY EXECUTIVES
TABLE 85. CORZA MEDICAL: COMPANY SNAPSHOT
TABLE 86. CORZA MEDICAL: OPERATING SEGMENTS
TABLE 87. CORZA MEDICAL: PRODUCT PORTFOLIO
TABLE 88. CORZA MEDICAL: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 89. LIFEBOND LTD: KEY EXECUTIVES
TABLE 90. LIFEBOND LTD: COMPANY SNAPSHOT
TABLE 91. LIFEBOND LTD: OPERATING SEGMENTS
TABLE 92. LIFEBOND LTD: PRODUCT PORTFOLIO
TABLE 93. LIFEBOND LTD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 94. SURGICAL SPECIALTIES CORPORATION: KEY EXECUTIVES
TABLE 95. SURGICAL SPECIALTIES CORPORATION: COMPANY SNAPSHOT
TABLE 96. SURGICAL SPECIALTIES CORPORATION: OPERATING SEGMENTS
TABLE 97. SURGICAL SPECIALTIES CORPORATION: PRODUCT PORTFOLIO
TABLE 98. SURGICAL SPECIALTIES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 99. BIEGLER GMBH: KEY EXECUTIVES
TABLE 100. BIEGLER GMBH: COMPANY SNAPSHOT
TABLE 101. BIEGLER GMBH: OPERATING SEGMENTS
TABLE 102. BIEGLER GMBH: PRODUCT PORTFOLIO
TABLE 103. BIEGLER GMBH: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 104. COHERA MEDICAL INC: KEY EXECUTIVES
TABLE 105. COHERA MEDICAL INC: COMPANY SNAPSHOT
TABLE 106. COHERA MEDICAL INC: OPERATING SEGMENTS
TABLE 107. COHERA MEDICAL INC: PRODUCT PORTFOLIO
TABLE 108. COHERA MEDICAL INC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 109. INTEGRA LIFESCIENCES CORPORATION: KEY EXECUTIVES
TABLE 110. INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
TABLE 111. INTEGRA LIFESCIENCES CORPORATION: OPERATING SEGMENTS
TABLE 112. INTEGRA LIFESCIENCES CORPORATION: PRODUCT PORTFOLIO
TABLE 113. INTEGRA LIFESCIENCES CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
FIGURE 1. GLOBAL ABSORBABLE FIBRIN SEALANT PATCH MARKET, 2024 - 2033
FIGURE 2. SEGMENTATION OF ABSORBABLE FIBRIN SEALANT PATCH MARKET, 2024 - 2033
FIGURE 3. TOP INVESTMENT POCKET IN ABSORBABLE FIBRIN SEALANT PATCH MARKET
FIGURE 4. MODERATE BARGAINING POWER OF BUYERS
FIGURE 5. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 6. MODERATE THREAT OF NEW ENTRANTS
FIGURE 7. LOW THREAT OF SUBSTITUTION
FIGURE 8. HIGH COMPETITIVE RIVALRY
FIGURE 9. OPPORTUNITIES, RESTRAINTS AND DRIVERS: GLOBALABSORBABLE FIBRIN SEALANT PATCH MARKET
FIGURE 10. GLOBAL ABSORBABLE FIBRIN SEALANT PATCH MARKET SEGMENTATION, BY APPLICATION
FIGURE 11. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR GENERAL SURGERY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 12. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR CARDIOVASCULAR SURGERY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 13. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR WOUND MANAGEMENT, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 14. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR ORTHOPEDIC SURGERY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 15. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR UROLOGICAL SURGERY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 16. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OPHTHALMIC SURGERY, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 17. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 18. GLOBAL ABSORBABLE FIBRIN SEALANT PATCH MARKET SEGMENTATION, BY END USER
FIGURE 19. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR HOSPITALS AND CLINICS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 20. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 21. ABSORBABLE FIBRIN SEALANT PATCH MARKET FOR OTHERS, BY COUNTRY, 2024 - 2033 ($BILLION)
FIGURE 22. TOP WINNING STRATEGIES, BY YEAR, 2021-2023*
FIGURE 23. TOP WINNING STRATEGIES, BY DEVELOPMENT, 2021-2023*
FIGURE 24. TOP WINNING STRATEGIES, BY COMPANY, 2021-2023*
FIGURE 25. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 26. COMPETITIVE DASHBOARD
FIGURE 27. COMPETITIVE HEATMAP: ABSORBABLE FIBRIN SEALANT PATCH MARKET
FIGURE 28. TOP PLAYER POSITIONING, 2023
FIGURE 29. JOHNSON AND JOHNSON: NET SALES, 2021-2023 ($BILLION)
FIGURE 30. JOHNSON AND JOHNSON: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 31. JOHNSON AND JOHNSON: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 32. BAXTER INTERNATIONAL INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 33. BAXTER INTERNATIONAL INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 34. BAXTER INTERNATIONAL INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 35. TAKEDA PHARMACEUTICAL COMPANY LIMITED: NET SALES, 2021-2023 ($BILLION)
FIGURE 36. TAKEDA PHARMACEUTICAL COMPANY LIMITED: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 37. TAKEDA PHARMACEUTICAL COMPANY LIMITED: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 38. BECTON, DICKINSON AND COMPANY.: NET SALES, 2021-2023 ($BILLION)
FIGURE 39. BECTON, DICKINSON AND COMPANY.: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 40. BECTON, DICKINSON AND COMPANY.: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 41. CORZA MEDICAL: NET SALES, 2021-2023 ($BILLION)
FIGURE 42. CORZA MEDICAL: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 43. CORZA MEDICAL: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 44. LIFEBOND LTD: NET SALES, 2021-2023 ($BILLION)
FIGURE 45. LIFEBOND LTD: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 46. LIFEBOND LTD: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 47. SURGICAL SPECIALTIES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 48. SURGICAL SPECIALTIES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 49. SURGICAL SPECIALTIES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 50. BIEGLER GMBH: NET SALES, 2021-2023 ($BILLION)
FIGURE 51. BIEGLER GMBH: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 52. BIEGLER GMBH: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 53. COHERA MEDICAL INC: NET SALES, 2021-2023 ($BILLION)
FIGURE 54. COHERA MEDICAL INC: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 55. COHERA MEDICAL INC: REVENUE SHARE, BY REGION, 2023 (%)
FIGURE 56. INTEGRA LIFESCIENCES CORPORATION: NET SALES, 2021-2023 ($BILLION)
FIGURE 57. INTEGRA LIFESCIENCES CORPORATION: REVENUE SHARE, BY SEGMENT, 2023 (%)
FIGURE 58. INTEGRA LIFESCIENCES CORPORATION: REVENUE SHARE, BY REGION, 2023 (%)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security